GlaxoSmithKlineGlaxoSmithKline


Latest Articles

1 day, 21 hours ago

Stick to Biggest and Safest Names: Strategist spacer

Stocks are definitely going up in a 2-3 week view, Douglas Isles from Pengana Capital said Tuesday. He told CNBC that some of the best ways to invest in developing ... CNBC : All News, Video and Posts related to TOPIC: Investment Strategy - 1 a.m. Tuesday 9th March 2010 PST View Article Related Articles Email to Friend

2 days, 9 hours ago

Nabi closes license deal with GlaxoSmithKline spacer

Nabi Pharmaceuticals said Monday it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline. The deal is potentially worth more than $500 million, including a ... SacBee -- Wire Business News - 1 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Nabi Pharmaceuticals closes GlaxoSmithKline license deal for experimental smoking vaccine spacer

StarTribune.com Business - 12:57 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Nabi closes license deal with GlaxoSmithKline spacer

Nabi Pharmaceuticals said Monday it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline. The deal is potentially worth more than $500 million, including a ... SFGate: Business & Technology - 12:56 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Nabi Closes License Deal With GlaxoSmithKline spacer

Nabi Pharmaceuticals closes GlaxoSmithKline license deal for experimental smoking vaccine GlaxoSmithKline - Health - License - Vaccination - Vaccine ABC News: Money - 12:55 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Nabi closes license deal with GlaxoSmithKline spacer

Nabi Pharmaceuticals said Monday it closed an option and license agreement for the smoking vaccine candidate NicVAx with GlaxoSmithKline. San Diego Union-Tribune Business - 12:55 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Also reported by:
Nabi Biopharmaceuticals closes on GSK deal spacer

Print Reprints RSS Feeds LinkedIn Share Comments Send this story to a friend Email address of friend (insert comma between multiple addresses): Your email address: Add a brief note: Enter ... WN.com - Top English Stories - 12:07 p.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

Nabi Closes License Deal With GlaxoSmithKline spacer

Nabi Pharmaceuticals Closes GlaxoSmithKline License Deal For Experimental Smoking Vaccine GameCore: CBSNews.com - 11:55 a.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

XenoPort slashes half its work force spacer

Drug developer XenoPort Inc. is cutting half of its staff and eliminating drug discovery work in order to save money as it prepares to focus solely on drugs already in ... SacBee -- Wire Business News - 8:15 a.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

XenoPort Slashes Half Its Work Force spacer

As it faces possible further Horizant studies, XenoPort cuts half its staff & trims R&D work Food and Drug Administration - GlaxoSmithKline - Restless legs syndrome - United States - ... ABC News: Money - 8:11 a.m. Monday 8th March 2010 PST View Article Related Articles Email to Friend

1,615 articles match your search
123456...4950>

News Volume and Sentiment

Chart News Volume
News Sentiment Positive Negative

Related Organizations

Related People

Related Locations

Related Publishers